February 8, 2007
Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industries, announced today that its Managed Markets practice will again assume a leadership role at the Center for Business Intelligence (
Kevin Barnett, Senior Vice President and head of the Managed Markets practice at Campbell Alliance, will serve as conference chairperson.
“This conference comes at a critical time for the pharmaceutical and biotech industries,” stated Mr. Barnett. “Based on the feedback we’ve heard from decision makers at leading Part D plans, there are strong indications that plan sponsors will manage their formularies more tightly and push more aggressively for rebate and price concessions during contracting interactions for 2008. For most manufacturers, the stakes are still high with Part D, so they need to conduct adequate research and analyses to make informed decisions over the next month or so,” he continued.
In addition, on February 12 at , Tony Lanzone, Senior Practice Executive in the firm’s Managed Markets practice, will present a session titled “Keys to Developing a Coordinated Channel Strategy for Managed Markets.” The presentation will focus on the importance of performing the following effectively:
Mr. Lanzone brings more than 15 years of industry experience to Campbell Alliance, including sales at a “top five” pharmaceutical company and consulting in the hospital and pharmaceutical sectors. Prior to joining the firm, he served as a Senior Director in Premier’s HealthCare Informatics division.
For more information on the SMCA, please visit http://www.cbinet.com/medicare.
About the Managed Markets Practice at
The Managed Markets Practice at Campbell Alliance has helped dozens of clients identify and prepare for the implications of the Medicare Modernization Act. Early on, the practice started working with clients in the pharmaceutical industry to anticipate what provisions the new Medicare legislation might contain and how such provisions could affect their businesses under various scenarios. Campbell Alliance continues to help clients develop Medicare-related strategies at the corporate and product levels. Overall, the Practice helps clients be more effective in marketing and selling in an environment where payers are increasingly important, tackling issues from pricing and contracting to value proposition development and pull-through.
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales. From its locations in